Search by Drug Name or NDC
NDC 72618-3001-02 NURTEC ODT 75 mg/1 Details
NURTEC ODT 75 mg/1
NURTEC ODT is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is RIMEGEPANT SULFATE.
MedlinePlus Drug Summary
Rimegepant is used to prevent and treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Rimegepant is in a class of medications called calcitonin gene-related peptide receptor antagonists. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
Related Packages: 72618-3001-02Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Rimegepant
Product Information
| NDC | 72618-3001 |
|---|---|
| Product ID | 72618-3001_2324b31a-d161-463e-9c3a-b4b611fd3de1 |
| Associated GPIs | |
| GCN Sequence Number | 080787 |
| GCN Sequence Number Description | rimegepant sulfate TAB RAPDIS 75 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 47762 |
| HICL Sequence Number | 046383 |
| HICL Sequence Number Description | RIMEGEPANT SULFATE |
| Brand/Generic | Brand |
| Proprietary Name | NURTEC ODT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | rimegepant sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIMEGEPANT SULFATE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212728 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72618-3001-02 (72618300102)
| NDC Package Code | 72618-3001-2 |
|---|---|
| Billing NDC | 72618300102 |
| Package | 4 DOSE PACK in 1 CARTON (72618-3001-2) / 1 BLISTER PACK in 1 DOSE PACK (72618-3001-1) / 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Marketing Start Date | 2020-03-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |